Ending Ebola

descriptionPublicationkeyboard_double_arrow_right Article , Other literature type 01 Dec 2019 English Publisher:Elsevier BVJournal:Immunity, volume 51, page 969 (issn: 1074-7613,

doi: 10.1016/j.immuni.2019.11.010

pmid: 31951540

Ending Ebola

- Summary
- Subjects
- Metrics

Abstract

Promising vaccines and results from recent clinical trials of therapeutic antibodies against Ebola virus offer hope for an end to this devastating disease. We asked three investigators in the field to share their views on the remaining challenges and important future research directions as we work toward controlling Ebola virus infection.

Keywords

Humans, Ebola Vaccines, Hemorrhagic Fever, Ebola, Ebolavirus

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average

Found an issue? Give us feedback

Average

hybrid

Beta

SDGs Suggest

3. Good health

Beta

SDGs:

3. Good health,